Clinical trials
Hepatitis C trials in Poland
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
55 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2004 | 1 |
| 2005 | 2 |
| 2006 | 1 |
| 2007 | 3 |
| 2008 | 3 |
| 2009 | 4 |
| 2010 | 7 |
| 2011 | 10 |
| 2012 | 10 |
| 2013 | 2 |
| 2014 | 1 |
| 2015 | 1 |
| 2017 | 5 |
| 2018 | 1 |
| 2019 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 44 |
| Terminated | 6 |
| Unknown status | 2 |
| Active, not recruiting | 1 |
| Enrolling by invitation | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Gilead Sciences | 9 |
| Bristol-Myers Squibb | 8 |
| Debiopharm International SA | 6 |
| AbbVie | 5 |
| Janssen R&D Ireland | 5 |
| GlaxoSmithKline | 3 |
| Human Genome Sciences Inc. | 3 |
| Tibotec Pharmaceuticals, Ireland | 2 |
| Astellas Pharma Inc | 1 |
| Atea Pharmaceuticals, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hepatitis C | 55 |
| Hepatitis C, Chronic | 23 |
| Hepatitis | 6 |
| Liver Diseases | 4 |
| Acquired Immunodeficiency Syndrome | 2 |
| Fibrosis | 2 |
| Hepatitis B | 2 |
| Virus Diseases | 2 |
| Acidosis, Lactic | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 76 to 55 of 55. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.